Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 3/2010

01-09-2010 | Nephrology - Letter to the Editor

The other end of spectrum in hypertension: ‘Idiopathic nodular glomerulosclerosis’

Authors: Rahil Kasmani, Thanigaiarsu Thiyagarajan, Rawan Narwal-Chadha, Kelechi Okoli, Farzan Irani

Published in: International Urology and Nephrology | Issue 3/2010

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Kuppachi S, Idris N, Chander PN, Yoo J (2006) Idiopathic nodular glomerulosclerosis in a non-diabetic hypertensive smoker–case report, review of literature. Nephrol Dial Transplant 21(12):3571–3575CrossRefPubMed
2.
Wu L, Juurlink BH (2002) Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 39(3):809–14
3.
Miyata T, de Strihou C, Ueda Y, Ichimori K, Inagi R, Onogi H, Ishikawa N, Nangaku M, Kurokawa K (2002) Angiotensin II receptor antagonists, angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J Am Soc Nephrol 13(10):2478–2487CrossRefPubMed
4.
Geroldi D, Falcone C, Emanuele E, D’Angelo A, Calcagnino M, Buzzi MP, Scioli GA, Fogari R (2005) Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension. J Hypertens 23:1725–1729CrossRefPubMed
5.
Williams B (1998) A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy? Miner Electrolyte Metab 24(6):400–405CrossRefPubMed
6.
Yoshimura M, Kida H, Saito Y, Yokoyama H, Tomosugi N, Abe T, Hattori N (1985) Peculiar glomerular lesions in Takayasu’s arteritis. Clin Nephrol 24(3):120–127PubMed
7.
Zhou XJ, Saxena R, Liu Z, Vaziri ND (2008) Silva FG: renal senescence in 2008: progress and challenges. Int Urol Nephrol 40:823–839CrossRefPubMed
Metadata
Title
The other end of spectrum in hypertension: ‘Idiopathic nodular glomerulosclerosis’
Authors
Rahil Kasmani
Thanigaiarsu Thiyagarajan
Rawan Narwal-Chadha
Kelechi Okoli
Farzan Irani
Publication date
01-09-2010
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 3/2010
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-009-9614-1

Other articles of this Issue 3/2010

International Urology and Nephrology 3/2010 Go to the issue

Nephrology - Translational Section

Epithelial–mesenchymal transition to be or not to be? Is the answer yes and no at the same time?

Nephrology – Editorial

Geriatric renal palliative care is coming of age

Erratum

Erratum to: Combination antioxidant effect of α-tocoferol and erdosteine in ischemia–reperfusion injury in rat model

Urology - Original Paper

Validation of Epstein criteria of insignificant prostate cancer in Middle East patients

Urology - Original Paper

Single-knot running suture anastomosis (one-knot pyeloplasty) for laparoscopic dismembered pyeloplasty: training model on a porcine bladder and clinical results

Urology - Original Paper

Comparison of the differences in circadian autonomic function in hyperlipidemic men with and without erectile dysfunction
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits